PL1735006T3 - Cząstki polimerowe zawierające substancję czynną - Google Patents

Cząstki polimerowe zawierające substancję czynną

Info

Publication number
PL1735006T3
PL1735006T3 PL05716516T PL05716516T PL1735006T3 PL 1735006 T3 PL1735006 T3 PL 1735006T3 PL 05716516 T PL05716516 T PL 05716516T PL 05716516 T PL05716516 T PL 05716516T PL 1735006 T3 PL1735006 T3 PL 1735006T3
Authority
PL
Poland
Prior art keywords
polymer particles
active agents
particles containing
containing active
range
Prior art date
Application number
PL05716516T
Other languages
English (en)
Inventor
Werner Siol
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of PL1735006T3 publication Critical patent/PL1735006T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/04—Acids; Metal salts or ammonium salts thereof
    • C08F220/06—Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10—Esters
    • C08F220/12—Esters of monohydric alcohols or phenols
    • C08F220/14—Methyl esters, e.g. methyl (meth)acrylate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Colloid Chemistry (AREA)
PL05716516T 2004-04-05 2005-04-02 Cząstki polimerowe zawierające substancję czynną PL1735006T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004016685 2004-04-05
PCT/EP2005/003493 WO2005097197A1 (de) 2004-04-05 2005-04-02 Wirkstoffhaltige polymerteilchen
EP05716516A EP1735006B1 (de) 2004-04-05 2005-04-02 Wirkstoffhaltige polymerteilchen

Publications (1)

Publication Number Publication Date
PL1735006T3 true PL1735006T3 (pl) 2008-02-29

Family

ID=34963958

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05716516T PL1735006T3 (pl) 2004-04-05 2005-04-02 Cząstki polimerowe zawierające substancję czynną

Country Status (14)

Country Link
US (1) US20070224274A1 (pl)
EP (1) EP1735006B1 (pl)
JP (1) JP2007531720A (pl)
CN (1) CN100566755C (pl)
AT (1) ATE374044T1 (pl)
BR (1) BRPI0509005A (pl)
CA (1) CA2558853A1 (pl)
DE (1) DE502005001579D1 (pl)
ES (1) ES2292116T3 (pl)
IL (1) IL177777A (pl)
PL (1) PL1735006T3 (pl)
RU (1) RU2363493C2 (pl)
WO (1) WO2005097197A1 (pl)
ZA (1) ZA200609155B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007036494A2 (de) * 2005-09-30 2007-04-05 Basf Se Agrochemische formulierung umfassend wirkstoffhaltige polymerteilchen
DE102008054391B4 (de) 2008-12-08 2019-03-07 Wacker Chemie Ag Partikuläre Zubereitungen mit Dispergierhilfsmitteln und Verfahren zur Herstellung der Zubereitungen
US9993793B2 (en) 2010-04-28 2018-06-12 The Procter & Gamble Company Delivery particles
US9186642B2 (en) 2010-04-28 2015-11-17 The Procter & Gamble Company Delivery particle
EP2694016B1 (en) 2011-04-07 2017-05-24 The Procter and Gamble Company Shampoo compositions with increased deposition of polyacrylate microcapsules
MX2013010980A (es) 2011-04-07 2013-10-30 Procter & Gamble Composiciones de limpieza personal con deposito mejorado de microcapsulas de poliacrilato.
US8980292B2 (en) 2011-04-07 2015-03-17 The Procter & Gamble Company Conditioner compositions with increased deposition of polyacrylate microcapsules
US20140056981A1 (en) * 2012-08-21 2014-02-27 Centro De Investigacion En Quimica Aplicada Method for producing drug-loaded polymeric nanoparticles by polymerization in presence of drugs
DE102018129419A1 (de) * 2018-11-22 2020-05-28 Johannes Gutenberg-Universität Mainz Acrylat-Copolymer für galenische Anwendungen

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
USRE28316E (en) * 1968-09-03 1975-01-21 Entrapment compositions and processes
US3629392A (en) * 1969-08-15 1971-12-21 Gilbert S Banker Entrapment compositions and processes
DE2135072B2 (de) * 1971-07-14 1973-05-24 Verfahren zur erzeugung hochglaenzender oberflaechen auf dekorpapieren
DK143689C (da) * 1975-03-20 1982-03-15 J Kreuter Fremgangsmaade til fremstilling af en adsorberet vaccine
NO141367C (no) * 1976-11-22 1980-02-27 Sintef Framgangsmaate for framstilling av findelte emulsjoner av et litt vannloeselig materiale
DE3116995A1 (de) * 1981-04-29 1982-11-25 Röhm GmbH, 6100 Darmstadt Latex zur immobilisierung von biologisch wirksamen substanzen
DE3208791A1 (de) * 1982-03-11 1983-09-22 Röhm GmbH, 6100 Darmstadt Verfahren zum ueberziehen von arzneiformen mittes eines in wasser dispergierten ueberzugsmittels
US5106903A (en) * 1984-12-17 1992-04-21 Lehigh University Preparation of large particle size monodisperse latexes
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
DE4328069A1 (de) * 1993-08-20 1995-02-23 Henning Berlin Gmbh Mikropartikel, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneimitteln
WO1995022963A1 (en) * 1994-02-28 1995-08-31 Medinova Medical Consulting Gmbh Drug targeting system, method for preparing same and its use
WO1996024377A1 (de) * 1995-02-10 1996-08-15 Christian Noe Partikuläre arzneiform
US6165988A (en) * 1995-02-10 2000-12-26 Christian Noe Medicament in particulate form
US20040018236A1 (en) * 1995-05-08 2004-01-29 Robert Gurny Nanoparticles for oral administration of pharmaceutical agents of low solubility
ES2242198T3 (es) * 1995-10-25 2005-11-01 Octoplus B.V. Poliacrilatos y poli(alquil) acrilatos cationicos o las correspondientes acrilamidas para utilizar en sistemas de transfeccion sinteticos.
DE10220470A1 (de) * 2002-04-30 2003-11-20 Roehm Gmbh ph-sensitives Polymer

Also Published As

Publication number Publication date
WO2005097197A1 (de) 2005-10-20
RU2363493C2 (ru) 2009-08-10
ATE374044T1 (de) 2007-10-15
ES2292116T3 (es) 2008-03-01
BRPI0509005A (pt) 2007-08-07
CN1938049A (zh) 2007-03-28
RU2006139003A (ru) 2008-05-20
CN100566755C (zh) 2009-12-09
EP1735006A1 (de) 2006-12-27
IL177777A0 (en) 2006-12-31
DE502005001579D1 (de) 2007-11-08
CA2558853A1 (en) 2005-10-20
IL177777A (en) 2010-05-31
EP1735006B1 (de) 2007-09-26
ZA200609155B (en) 2008-06-25
JP2007531720A (ja) 2007-11-08
US20070224274A1 (en) 2007-09-27

Similar Documents

Publication Publication Date Title
IL177777A0 (en) Polymer particles containing active agents
ATE288956T1 (de) Verwendung eines amphoteren polymeres zur behandlung ausgewählter harter oberflächen
Arora et al. Antibacterial polymers–a mini review
TW200727912A (en) Amphiphilic block copolymers and nano particles comprising the same
CA2112411A1 (en) Polymeric Surface Coatings
WO1997026864A3 (en) Methods and compositions for enhancing the bioadhesive properties of polymers
EP1891987A3 (en) Medical implant bearing material
EP1849487A3 (en) Film-forming compositions and their uses
TW200518775A (en) Pharmaceutical formulations for the prolonged release of active principle(s) and their applications, especially therapeutic applications
MXPA03011205A (es) Caucho de nitrilo hidrogenado de peso molecular bajo.
HK1058620A1 (en) Low salt forms of polyallylamine
MXPA02012601A (es) Polimeros radicales cationicos o anfotericos autoadhesivos y su uso en cosmeticos.
WO2002044225A3 (de) Siliziummodifizierte kammpolymere auf basis von acryloyldimethyltaurinsäure (2-acrylamido-2-methyl-1-propansulfonsäure)
ATE553754T1 (de) Pharmazeutische zusammensetzung mit kontrollierter wirkstoffabgabe für wirkstoffe mit guter löslichkeit in wasser
TW200635963A (en) Partially neutralized anionic (meth)acrylate copolymer
MXPA06000029A (es) Dispersion polimerica acuosa y uso de la misma en cosmeticos.
MXPA05006688A (es) Conjugados de polimero con una variante de cianovirina.
MX341715B (es) Polímeros anfifílicos de autoensamblaje como agentes anticáncer.
ATE438385T1 (de) Pharmazeutische zusammensetzung
EP1539109A4 (en) COPOLYMER MICEL COMPOSITION WITH IMPROVED CAPACITY CAPACITY CAPACITY CAPACITY CAPACITY INCREASE AND PROLONGED DRUG RELEASE CAPACITY
ATE328960T1 (de) Latex mit modifizierten eigenschaften durch zugabe eines wasserlöslichen amphiphilen polymers
FR2871701B1 (fr) Biomateriaux bioactifs pour le relarguage controle de principes actifs
JP2007504132A5 (pl)
RS70704A (en) Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
CA2243323A1 (fr) Poudres redispersables dans l'eau de polymeres filmogenes prepares a partir de monomeres a insaturation ethylenique